Delivery Order SPE2DB22D1202-SPE2DB25FVLU9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,580.52 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on November 13, 2025, with completion expected by November 14, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement of this diabetes medication from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen (0.5ml), a diabetes medication. This firm fixed-price delivery order was awarded competitively without a set-aside designation on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,632.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen (0.5 ml), a diabetes medication. The order was competitively awarded with no set-aside designation and is scheduled for completion by October 27, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance, aligning with the company's role as a primary pharmaceutical distributor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,897.78 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens (a diabetes medication) on September 3, 2025, with a completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a relatively small transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $7,131.67 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by August 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a $43,281.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on September 22, 2025, with completion scheduled for September 23, 2025. This non-set-aside contract represents a direct purchase of the diabetes medication to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order...
- The Defense Logistics Agency awarded a delivery order valued at $1,005.80 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,499.68 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, with a completion date of November 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,267.45 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of April 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract was awarded on October 21, 2025, with an ultimate completion date of October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLU9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pens (0.5 ml units), a diabetes management medication. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in that same city. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and medical test kits across multiple therapeutic domains, demonstrating AmerisourceBergen's critical role in federal medical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/18/25 |